Clinical Trials
Cancer clinical trials help answer important questions about medical care in an effort to develop new and improved ways to treat all patients with cancer and those who will develop cancer in the future.
Find current clinical trials offered by Duke Cancer Institute:
Research Overview
The Duke Cancer Institute’s multidisciplinary team of physician-scientists and associated health specialists forms a network of expertise that speeds laboratory discoveries into more effective ways to treat and prevent urologic cancers.
We have been involved in several unique discoveries that have broadened our understanding of how these diseases arise and how to prevent them. For example:
- A Duke investigator-initiated trial is studying the anti-tumor activity of two drugs in patients with metastatic non-clear cell renal cell carcinoma.
- A number of clinical trials are currently in progress for bladder cancer patients and range from studies of new diagnostic tests to novel treatment regimens for cancer.
- Duke was one of only 10 hospitals in the country to host a clinical trial for the drug sunitinib, which was shown in the trial to be seven times more effective than other kidney cancer drugs. Shortly after the trial, the FDA approved the drug.
- Researchers across several Duke departments and centers are studying the genomic profiles of kidney tumors, which may lead to “personalized medicine” where the patients’ genomic profile will guide the treatment.
Contact Us
|
Careers
|
Make a Gift
|
Site Map
